CPSI Biotech (CPSI) is a medical technology development company. It carries out the development and design of life science research products and cryo-medical devices. The company also offers contract research services, licensing or sales
in support of diverse clinical and research applications, devices and intellectual property for commercialization ventures among others. Its products find their application in cancer, cardiovascular disease treatments and cell therapy bioprocessing. CPSI is headquartered in Owego, New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
in support of diverse clinical and research applications, devices and intellectual property for commercialization ventures among others. Its products find their application in cancer, cardiovascular disease treatments and cell therapy bioprocessing. CPSI is headquartered in Owego, New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CPSI Biotech
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- CPSI Biotech Company Overview
- CPSI Biotech Company Snapshot
- CPSI Biotech Pipeline Products and Ongoing Clinical Trials Overview
- CPSI Biotech - Pipeline Analysis Overview
- CPSI Biotech - Key Facts
- CPSI Biotech - Major Products and Services
- CPSI Biotech Pipeline Products by Development Stage
- CPSI Biotech Pipeline Products Overview
- CryoInject
- CryoInject Product Overview
- CryoPellet
- CryoPellet Product Overview
- FACSGuard
- FACSGuard Product Overview
- FrostBite
- FrostBite Product Overview
- FrostBite-BC
- FrostBite-BC Product Overview
- ICEolate Catheter
- ICEolate Catheter Product Overview
- ICEolate Catheter With Spot Ablation Tip
- ICEolate Catheter With Spot Ablation Tip Product Overview
- ICEolate Surgical Probe With Control Handle
- ICEolate Surgical Probe With Control Handle Product Overview
- ICEolate Surgical Probe With Flexible Ablation Tip
- ICEolate Surgical Probe With Flexible Ablation Tip Product Overview
- Pressurized Sub-Cooled Nitrogen System
- Pressurized Sub-Cooled Nitrogen System Product Overview
- QuadProbe-RCC
- QuadProbe-RCC Product Overview
- SensitICERS
- SensitICERS Product Overview
- Super-Critical Nitrogen (SCN) Cryoablation Device
- Super-Critical Nitrogen (SCN) Cryoablation Device Product Overview
- TGpak
- TGpak Product Overview
- CPSI Biotech - Key Competitors
- CPSI Biotech - Key Employees
- CPSI Biotech - Locations And Subsidiaries
- Head Office
- Recent Developments
- CPSI Biotech, Recent Developments
- May 19, 2022: CPSI pilots clinical lens to ease provider data burdens
- Aug 05, 2020: CPSI aligns with Google Cloud to support innovation and enhance product delivery and performance
- Jul 08, 2020: New innovations from American HealthTech enhance decision making within clinical workflow and allow for faster communication to facility residents and family members
- Oct 16, 2019: CPSI partners with customers to lower costs, improve operations and increase revenue With nTrust Program
- Mar 19, 2018: In vitro study details the increased performance and potential of CPSI’s Supercritical Nitrogen cryoablation device for the epicardial based ablation of cardiac tissue
- Jan 12, 2018: In Vitro study shows combinatorial ablative strategies yield improved destruction of pancreatic cancer cells
- Sep 12, 2017: CPSI Biotech receives multi-year Phase II grant from the National Cancer Institute to develop FrostBite Cryoablation Technology for the Treatment of Pancreatic Cancer
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- CPSI Biotech Pipeline Products and Ongoing Clinical Trials Overview
- CPSI Biotech Pipeline Products by Equipment Type
- CPSI Biotech Pipeline Products by Indication
- CPSI Biotech, Key Facts
- CPSI Biotech, Major Products and Services
- CPSI Biotech Number of Pipeline Products by Development Stage
- CPSI Biotech Pipeline Products Summary by Development Stage
- CryoInject - Product Status
- CryoInject - Product Description
- CryoPellet - Product Status
- CryoPellet - Product Description
- FACSGuard - Product Status
- FACSGuard - Product Description
- FrostBite - Product Status
- FrostBite - Product Description
- FrostBite-BC - Product Status
- FrostBite-BC - Product Description
- ICEolate Catheter - Product Status
- ICEolate Catheter - Product Description
- ICEolate Catheter With Spot Ablation Tip - Product Status
- ICEolate Catheter With Spot Ablation Tip - Product Description
- ICEolate Surgical Probe With Control Handle - Product Status
- ICEolate Surgical Probe With Control Handle - Product Description
- ICEolate Surgical Probe With Flexible Ablation Tip - Product Status
- ICEolate Surgical Probe With Flexible Ablation Tip - Product Description
- Pressurized Sub-Cooled Nitrogen System - Product Status
- Pressurized Sub-Cooled Nitrogen System - Product Description
- QuadProbe-RCC - Product Status
- QuadProbe-RCC - Product Description
- SensitICERS - Product Status
- SensitICERS - Product Description
- Super-Critical Nitrogen (SCN) Cryoablation Device - Product Status
- Super-Critical Nitrogen (SCN) Cryoablation Device - Product Description
- TGpak - Product Status
- TGpak - Product Description
- CPSI Biotech, Key Employees
- Glossary
- CPSI Biotech Pipeline Products by Equipment Type
- CPSI Biotech Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Galil Medical Inc
- CSA Medical Inc
- Medtronic USA Inc
